New York, NY -- (SBWIRE) -- 12/05/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Oi SA (ADR) (NYSE:OIBR), Canadian Solar Inc (NASDAQ:CSIQ), Oncomed Pharmaceuticals Inc (NASDAQ:OMED), BAE Systems PLC (ADR) (OTCMKTS:BAESY)
Oi SA (ADR) (NYSE:OIBR) the stock opened the session at $1.59 but then moved to $1.72. At that price, the stock showed a positive performance of 8.861%. Oi SA, formerly Brasil Telecom SA, is a Brazil-based holding company engaged in the telecommunication sector. The Company is primarily involved in the provision of fixed telephony services in Brazilian states of Acre, Rondonia, Mato Grosso, Mato Grosso do Sul, Tocantins, Goias, Parana, Santa Catarina and Rio Grande do Sul. Additionally, it offers a range of integrated telecommunication services, including mobile telecommunication services, data transmission and Internet service provider (ISP) services, among others. The Company provides services to residential and corporate customers.
Will OIBR Continue To Move Higher? Find Out Here
Canadian Solar Inc (NASDAQ:CSIQ) opened the session at $28.85 and closed the session at $30.28. The stock showed a positive performance of 2.78% in previous trading session. Canadian Solar Inc. (CSI) designs, develops, and manufactures solar wafers, cells and solar module products that convert sunlight into electricity for a variety of uses. The Company’s products include a range of solar modules built to general specifications for use in a range of residential, commercial and industrial solar power generation systems. Specialty solar modules and products consist of customized solar modules that its customers incorporate into their own products, such as building integrated photovoltaic modules (BIPV) modules.
For How Long CSIQ will fight for Profitability? Read This Trend Analysis report
Oncomed Pharmaceuticals Inc (NASDAQ:OMED) opened the session at $30.15 and closed the session at $29.65. The stock showed a positive performance of 7.04% in previous trading session. OncoMed Pharmaceuticals, Inc. (OncoMed) is a clinical development-stage biopharmaceutical company. The Company focuses on discovering and developing monoclonal antibody therapeutics targeting cancer stem cells (CSCs). It utilizes its technologies to identify, isolate and evaluate CSCs; identify and/or validate multiple potential targets and pathways critical to CSC self-renewal and differentiation; and develop targeted antibody and other protein-based therapeutics that are designed to modulate these CSC targets and inhibit the growth of CSCs.
Why Should Investors Buy OMED After The Recent Gain? Just Go Here and Find Out
BAE Systems PLC (ADR) (OTCMKTS:BAESY) the stock advanced 0.62% and finished the session at $27.77. Traded with volume of 136,185.00 shares in the prior session and the average volume of the stock remained 135,268.00 shares. The beta of the stock remained 0.86. BAE Systems plc (BAE Systems) is a global defence, aerospace and security company. BAE Systems delivers, a range of products and services for air, land and naval forces, as well as advanced electronics, security, information technology solutions and support services. The Company operates in five segments: Electronic Systems consists of the United States- and United Kingdom-based electronics activities.
Will BAESY Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)